Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

LANNETT COMPANY, INC. (LCI)
Mes dernières consult.
Most popular
Report
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

The firm also manufactures oral dosage forms including, tablets and capsules.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involve analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging.

Lannett was founded in 1942 and is headquartered in Philadelphia, PA
Managers
NameAgeSinceTitle
Timothy C. Crew, MBA-2018Chief Executive Officer & Director
Jeffrey Farber572003Chairman
John Kozlowski, MBA462009Chief Operating Officer, VP-Financial Operations
Martin P. Galvan, CPA662011CFO, Treasurer & Vice President-Finance
Robert Ehlinger612006Chief Information Officer & VP-logistics
Kristin A. Arnold, PhD-2017Vice President-Research & Development
David A. Drabik502010Lead Independent Director
Paul Taveira582012Independent Director
James M. Maher652013Independent Director
Albert R. Paonessa III572015Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 38,305,589 28,629,000 74.7% 638,178 1.7% 74.7%
Shareholders
NameEquities%
Telemus Capital LLC 8,195,570 21.7%
Jeffrey Farber 4,534,186 12.0%
BlackRock Fund Advisors 3,686,188 9.78%
Snow Capital Management LP 3,435,152 9.11%
David J. Farber 3,087,848 8.19%
Deerfield Management Company LP 3,087,587 8.19%
The Vanguard Group, Inc. 2,843,015 7.54%
LSV Asset Management 1,795,535 4.76%
Citadel Advisors LLC 1,279,452 3.39%
Managed Account Advisors LLC 1,143,762 3.03%
Company contact information
Lannett Co., Inc.
9000 State Road
Philadelphia, PA 19136

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.869
JOHNSON & JOHNSON5.47%397 981
NOVARTIS1.29%226 840
PFIZER1.99%220 129
ROCHE HOLDING LTD.-4.34%211 542
MERCK AND COMPANY8.90%167 050
AMGEN8.84%139 614
NOVO NORDISK A/S4.72%113 242
SANOFI-1.42%109 634
BAYER1.65%107 130
ABBOTT LABORATORIES3.93%103 688
BRISTOL-MYERS SQUIBB COMPANY1.63%103 570
ELI LILLY AND COMPANY1.22%94 078
GLAXOSMITHKLINE2.47%93 930
ASTRAZENECA-1.31%88 627
CELGENE CORPORATION-1.64%81 023
ALLERGAN PLC10.85%62 576
TAKEDA PHARMACEUTICAL CO LTD1.86%46 189
SHIRE-9.97%44 237
JIANGSU HENGRUI MEDICINE CO LTD10.74%33 634
CHUGAI PHARMACEUTICAL CO LTD2.77%29 605
Connections : Lannett Company, Inc.
Auburn Pharmaceuticals, Inc.
National Response Corp.
Grason-Stadler, Inc.
Cranbrook & Co. Llc
The American Institute of Certified Public Accountants
Generic Pharmaceutical Co.
© 2018 People , Fundamentals and Ownership